New strategy for COVID-19 vaccination: targeting the receptor-binding domain of the SARS-CoV-2 spike protein

$ 26.00

4.5 (214) In stock

Potential immunization strategy to protect ag

On the interactions of the receptor-binding domain of SARS-CoV-1 and SARS- CoV-2 spike proteins with monoclonal antibodies and the receptor ACE2 - ScienceDirect

Broadly neutralizing antibody could fight new COVID-19 variants - Boston Children's Answers

Browse Articles Cellular & Molecular Immunology

News & Comment Cellular & Molecular Immunology

COVID-eVax, An Electroporated DNA Vaccine Candidate, 55% OFF

Zinc and selenium supplementation in COVID-19 prevention and treatment: a systematic review of the experimental studies

Identification of vaccine targets & design of vaccine against SARS-CoV-2 coronavirus using computational and deep learning-based approaches [PeerJ]

The construct of a SARS-CoV-2 spike receptor-binding domain (RBD)

Structural and energetic analyses of SARS-CoV-2 N-terminal domain characterise sugar binding pockets and suggest putative impacts of variants on COVID-19 transmission - Computational and Structural Biotechnology Journal